NMPA Regulatory Framework for Multinational Clinical Trials
NMPA Regulatory Framework for Multinational Clinical Trials Understanding the NMPA’s Role in Multinational Clinical Trials in China Introduction Multinational clinical trials (MRCTs) have become the cornerstone of global drug development, ensuring that diverse patient populations are represented and regulatory requirements across regions are harmonized. China, with its rapidly expanding pharmaceutical market and significant patient pool,…
Read More “NMPA Regulatory Framework for Multinational Clinical Trials” »